BioRestorative Therapies to Report 2024 Financial Results and Host Conference Call on March 27, 2025
March 20, 2025 16:30 ET
|
BioRestorative Therapies, Inc
MELVILLE, N.Y., March 20, 2025 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a clinical stage regenerative medicine innovator focused...
Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Chief Financial Officer
March 20, 2025 16:30 ET
|
Dyne Therapeutics, Inc.
WALTHAM, Mass., March 20, 2025 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on advancing life-transforming therapeutics for people living with...
BioAge Labs Reports Full Year 2024 Financial Results and Provides Business Updates from the Fourth Quarter of 2024
March 20, 2025 16:30 ET
|
BioAge Labs, Inc.
Advancement of oral, brain-penetrant NLRP3 inhibitor BGE-102, with initial clinical data expected 2H25 Progression of preclinical next-generation APJ agonists for obesity New platform partnerships...
Context Therapeutics Reports Full Year 2024 Operating and Financial Results
March 20, 2025 16:22 ET
|
Context Therapeutics Inc.
CTIM-76 first patient dosed in January 2025 Cash and cash equivalents of $94.4 million as of December 31, 2024 Company expects its cash and cash equivalents will continue to fund operations into...
EXL to Host Investor Strategy Update Event on May 6 in New York
March 20, 2025 16:15 ET
|
ExlService Holdings, Inc.
NEW YORK, March 20, 2025 (GLOBE NEWSWIRE) -- ExlService Holdings, Inc. (NASDAQ: EXLS), a global data and AI company, today announced it will be holding an investor strategy update event on May 6, at...
NANOBIOTIX annonce la présentation de données issues de deux études de phase 1 évaluant JNJ-1900 (NBTXR3) lors du Congrès Européen sur le Cancer du Poumon
March 20, 2025 16:15 ET
|
Nanobiotix S.A.
Des données évaluant la sécurité et les premiers signes d’efficacité, y compris la mise à jour de la survie sans progression (SSP) locale, issues de la partie escalade de dose achevée d’une étude de...
NANOBIOTIX Announces Presentation of Data From Two Phase 1 Studies Evaluating JNJ-1900 (NBTXR3) at the European Lung Cancer Conference
March 20, 2025 16:15 ET
|
Nanobiotix S.A.
Data evaluating safety and early signals of efficacy including updated local PFS from the completed dose escalation part of a Phase 1 study of re-irradiation with JNJ-1900 (NBTXR3) for patients with...
PLBY Group Announces Adjournment of Special Meeting of Stockholders
March 20, 2025 16:15 ET
|
PLBY Group, Inc.
LOS ANGELES, March 20, 2025 (GLOBE NEWSWIRE) -- PLBY Group, Inc. (Nasdaq: PLBY) (the “Company” or “PLBY Group”), a leading pleasure and leisure lifestyle company and owner of Playboy, one of the...
SEALSQ Announces FY 2024 Audited Financial Results and Strategic Growth Plan for 2025
March 20, 2025 16:15 ET
|
SEALSQ
Geneva, Switzerland, March 20, 2025 (GLOBE NEWSWIRE) -- Schedules Conference Call and Webcast for Monday, March 24 at 10:00 am ET (3:00 pm CET) Ends the year with a strong cash position of...
Palomar Holdings, Inc. Announces Agreement to Acquire Advanced AgProtection
March 20, 2025 16:10 ET
|
Palomar Holdings, Inc
LA JOLLA, Calif., March 20, 2025 (GLOBE NEWSWIRE) -- Palomar Holdings, Inc. (NASDAQ:PLMR) (“Palomar” or the “Company”) today announced that it has entered into a definitive agreement to acquire...